Biotronik Introduces New External Pacemaker
May 15, 2012 — Biotronik Inc., began its U.S. launch of its new Reocor external pacemaker. The device is available in two models, for dual- and single-chamber pacing therapy, and offers individualized patient therapy, easy handling and flexibility in every detail.
“Reocor has an intuitive design to simplify its utility. Clearly marked dials display selectable parameter values. The dials are simple and customers have told us that they’re perfect for visualizing programmed settings with just a quick glance,” commented Rex Richmond, vice president of marketing, Biotronik. “As a result, the device is easy to use without extensive training.”
The new device also features an extended longevity that increases reliability and reduces costs over time. Extended battery service times of up to 600 hours for permanent pacing therapy (with the Reocor S model), supplemented with a backup power supply during battery replacement, ensures easy handling and longer continuous usage in daily practice.
Reocor, which effectively delivers individual solutions for a broad range of patients, accommodates high pacing outputs and high pacing rates— a capability that is especially important when caring for pediatric patients.
For more information: www.biotronik.com
More like this
- Biotronik Enrolls First Patients for ProMRI Clinical Trial Expansion
- Biotronik Begins U.S. Trial for MRI-Safe Pacemaker System
- Sorin Group’s Smallest Implantable Dual-Chamber Pacemaker Now Available in Canada
- External Pacemakers Feature Simplified Design
- FDA Approves First Single-Lead ICD With Atrial Sensing